SLC43A2 played an important role in suppressing anti-tumor immunity, however, precise inhibition of SLC43A2 of tumor cells in vivo was difficult since it was widely expressed in various tissues such as the placenta, small intestine enterocytes, kidney epithelium, and peripheral blood leukocytes (Chen and Chen, 2022). Here, SLC43A2 is linked to neoplasm.